Search results

Skip to results

Area of interest

Area of interest

Type

Type

Status

Status

Last updated

Last updated

Guidance programme

Advice programme

Showing 8461 to 8475 of 9079 results

  1. Baricitinib for treating severe or very severe alopecia areata in people 6 to 17 years [ID6541]

    In development Reference number: GID-TA11692 Expected publication date: TBC

    Technology appraisal guidance
    In development

  2. Benralizumab for previously treated severe nasal polyps [ID1659]

    Discontinued Reference number: GID-TA10818

    Technology appraisal guidance
    Discontinued

  3. Suspected cancer update

    In development Reference number: GID-QS10176 Expected publication date: TBC

    Quality standard
    In development

  4. Peezy Midstream for urine collection (MT446)

    In development Reference number: GID-HTG10892 Expected publication date: TBC

    HealthTech guidance
    In development

  5. Surgical vessel sealing systems (MT798)

    Discontinued Reference number: GID-HTG10894

    HealthTech guidance
    Discontinued

  6. Zio XT for detecting cardiac arrhythmias

    In development Reference number: GID-HTG10895 Expected publication date: TBC

    HealthTech guidance
    In development

  7. GID-MT567 Evoke Spinal Cord Stimulator for managing chronic neuropathic or ischaemic pain

    Discontinued Reference number: GID-HTG10896

    HealthTech guidance
    Discontinued

  8. Non-invasive skin closure devices for surgical incisions (MT775)

    Discontinued Reference number: GID-HTG10897

    HealthTech guidance
    Discontinued

  9. Etirinotecan pegol for treating breast cancer with brain metastases [ID881]

    Discontinued Reference number: GID-TA10066

    Technology appraisal guidance
    Discontinued

  10. Leukaemia (acute myeloid, relapsed, refractory) - vosaroxin [ID746]

    Discontinued Reference number: GID-TA10070

    Technology appraisal guidance
    Discontinued

  11. Anamorelin for treating anorexia and cachexia associated with non-small cell lung cancer [ID821]

    Discontinued Reference number: GID-TA10105

    Technology appraisal guidance
    Discontinued

  12. Rociletinib for previously treated EGFR T790M-positive metastatic non-small-cell lung cancer [ID883]

    Discontinued Reference number: GID-TA10045

    Technology appraisal guidance
    Discontinued

  13. Colorectal cancer (metastatic) - MABp1 (after previous treatment) [ID917]

    Discontinued Reference number: GID-TA10065

    Technology appraisal guidance
    Discontinued

  14. The IN.PACT drug-coated balloon for peripheral arterial disease (CANCELLED)

    Discontinued Reference number: GID-MT517

    Medical technologies guidance
    Discontinued

  15. Fordadistrogene movaparvovec for treating Duchenne muscular dystrophy [ID6133]

    Discontinued Reference number: GID-TA11044

    Technology appraisal guidance
    Discontinued